BridgeBio Oncology Therapeutics, Inc. (BBOT): SCHEDULE 13D/A filed Jul 6, 2026

Name: BridgeBio Oncology Therapeutics, Inc. SCHEDULE 13D/A (0001213900-26-075546)
Creator: BridgeBio Oncology Therapeutics, Inc.
Published: 2026-07-06

Form type: SCHEDULE 13D/A
Filing date: Jul 6, 2026
Accession number: 0001213900-26-075546
Filer: BridgeBio Oncology Therapeutics, Inc. (CIK 1869105)